ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 255 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $419,000 | +8.0% | 10,344 | -11.7% | 0.01% | -9.1% |
| Q3 2022 | $388,000 | -2.3% | 11,714 | +3.8% | 0.01% | +10.0% |
| Q2 2022 | $397,000 | -27.0% | 11,282 | -45.0% | 0.01% | +900.0% |
| Q2 2019 | $544,000 | +48.2% | 20,515 | +2.6% | 0.00% | 0.0% |
| Q1 2019 | $367,000 | +45.6% | 19,993 | -1.5% | 0.00% | 0.0% |
| Q4 2018 | $252,000 | -34.4% | 20,301 | +1.3% | 0.00% | 0.0% |
| Q3 2018 | $384,000 | +48.3% | 20,037 | +5.2% | 0.00% | 0.0% |
| Q2 2018 | $259,000 | +219.8% | 19,043 | +69.6% | 0.00% | – |
| Q1 2018 | $81,000 | – | 11,227 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,303 | $54,386,000 | 28.54% |
| JOHNSON & JOHNSON | 3,260,869 | $216,196,000 | 24.61% |
| ACT CAPITAL MANAGEMENT, LLC | 210,500 | $13,956,000 | 10.09% |
| Aquilo Capital Management, LLC | 700,426 | $46,438,000 | 5.27% |
| WEALTH EFFECTS LLC | 145,960 | $9,677,000 | 4.02% |
| Evolutionary Tree Capital Management, LLC | 115,580 | $7,663,000 | 3.68% |
| ACUTA CAPITAL PARTNERS, LLC | 105,500 | $6,995,000 | 2.94% |
| Privium Fund Management B.V. | 204,393 | $13,766,000 | 2.73% |
| L1 Capital Pty Ltd | 292,735 | $19,408,000 | 2.24% |
| Avidity Partners Management LP | 875,000 | $58,013,000 | 1.23% |